Ang II stimulation upregulates both TGF-β1 and CTGF expression in atrial fibroblasts and myocytes[15]; inhibition via ARB blunts atrial fibrosis in animal models[16, 17] and decreases the incidence of AF in human patients[18]. Here, CCN2 is linked to atrial fibrillation.